Skip to main content
SpringerLink
Log in

Migränemittel

  • Chapter
  • First Online:
Book cover Arzneiverordnungs-Report 2019

  • 2842 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Bird S, Derry S, Moore RA (2014) Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev 5: CD008616

    Google Scholar 

  • van den Broek RW, Bhalla P, VanDenBrink AM, de Vries R, Sharma HS, Saxena PR (2002) Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization. Cephalalgia 22:83–93

    Article  Google Scholar 

  • Deleu D, Hanssens Y (2000) Current and emerging second-generation triptans in acute migraine therapy: a comparative review. J Clin Pharmacol 40:687–700

    Article  CAS  Google Scholar 

  • Derry CJ, Derry S, Moore RA (2014) Sumatriptan (all routes of administration) for acute migraine attacks in adults – overview of Cochrane reviews. Cochrane Database Syst Rev 5: CD009108

    Google Scholar 

  • Diamond ML, Hettiarachchi J, Hilliard B, Sands G, Nett R (2004) Effectiveness of eletriptan in acute migraine: primary care for excedrin nonresponders. Headache 44:209–216

    Article  Google Scholar 

  • Diener HC, Gaul C, Kropp P (2018a) Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie (für die Deutschen Gesellschaft für Neurologie (DGN) in Zusammenarbeit mit der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG), www.dgn.org/leitlinien)

    Google Scholar 

  • Diener HC, Gaul C, Kropp P (2018b) Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln (Medication Overuse Headache = MOH), S1-Leitlini. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie (für die Deutschen Gesellschaft für Neurologie (DGN) in Zusammenarbeit mit der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG), www.dgn.org/leitlinien)

    Google Scholar 

  • Edvinsson L (2017) The Trigeminovascular Pathway: role of CGRP and CGRP receptors in migraine. Headache 57(Suppl 2):47–55

    Article  Google Scholar 

  • Eiland LS, Hunt MO (2010) The use of triptans for pediatric migraines. Paediatr Drugs 12:379–389

    Article  Google Scholar 

  • Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633–658

    Article  CAS  Google Scholar 

  • Gemeinsamer Bundesausschuss (2010): Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über die Änderung der Arzneimittel-Richtlinie: Anlage VI (Off-Label-Use) Valproinsäure bei der Migräneprophylaxe im Erwachsenenalter. BAnz. Nr. 190; (S. 4169) vom 15. Dez. 2010

    Google Scholar 

  • Gillman PK (2010) Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 50:264–272

    Article  Google Scholar 

  • Hargreaves R, Olesen J (2019) Calcitonin gene-related peptide modulators – The history and renaissance of a new migraine drug class. Headache 59:951–970

    Article  Google Scholar 

  • Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J (2015) A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS ONE 10(7):e130733

    Article  Google Scholar 

  • Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and otherheadache drugs. Neurology 57:1694–1698

    Article  CAS  Google Scholar 

  • Law S, Derry S, Moore RA (2016) Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults. Cochrane Database Syst Rev 4: CD008541

    PubMed  Google Scholar 

  • Le K, Yu D, Wang J, Ali AI, Guo Y (2017) Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials. J Headache Pain 18:69

    Article  Google Scholar 

  • Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Baillieres Clin Neurol 59:1011–1014

    CAS  Google Scholar 

  • Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013a) Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 6: CD010610

    Google Scholar 

  • Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013b) Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 6: CD010611

    Google Scholar 

  • Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63–70

    Article  CAS  Google Scholar 

  • Maasumi K, Tepper SJ, Kriegler JS (2017) Menstrual migraine and treatment options: review. Headache 57:194–208

    Article  Google Scholar 

  • Markham A (2018) Erenumab: First global approval. Drugs 78:1157–1161

    Article  CAS  Google Scholar 

  • Martin VT, Behbehani MM (2001) Toward a rational understanding of migraine trigger factors. Med Clin North Am 85:911

    Article  CAS  Google Scholar 

  • Pringsheim T, Davenport W, Mackie G, Worthington I, Aubé M, Christie SN, Gladstone J, Becker WJ, Canadian Headache Society Prophylactic Guidelines Development Group (2012) Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci 39(2 Suppl 2):S1–S59

    PubMed  Google Scholar 

  • Rapoport A, Winner P (2006) Nasal delivery of antimigraine drugs: clinical rationale and evidence base. Headache 46(Suppl 4):S192–S201

    Article  Google Scholar 

  • Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, Durec T, Klassen TP, Hartling L (2016) Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 4: CD005220

    PubMed  Google Scholar 

  • Roberto G, Raschi E, Piccinni C, Conti V, Vignatelli L, D’Alessandro R, De Ponti F, Poluzzi E (2015) Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia 35:118–131

    Article  CAS  Google Scholar 

  • Rolan PE (2012) Drug interactions with triptans: which are clinically significant? CNS Drugs 26:949–957

    Article  CAS  Google Scholar 

  • Shamliyan TA, Kane RL, Ramakrishnan R, Taylor FR (2013) Migraine in Children: Preventive Pharmacologic Treatments [Internet]. Effective Health Care Programm. Comparative Effectivness Review Number 108. Rockville (MD): Agency for Healthcare Research and Quality (US)

    Google Scholar 

  • Soldin OP, Tonning JM, Obstetric-Fetal Pharmacology Research Unit Network (2008) Serotonin syndrome associated with triptan monotherapy. N Engl J Med 358:2185–2186

    Article  CAS  Google Scholar 

  • Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, Vennemann M, Berger K (2010) Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia 30:207–213

    Article  CAS  Google Scholar 

  • Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ (2014) Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis. Cephalalgia 34:258–267

    Article  Google Scholar 

  • Xu H, Han W, Wang J, Li M (2016) Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. J Headache Pain 17:113

    Article  Google Scholar 

  • Xu XM, Liu Y, Dong MX, Zou DZ, Wei YD (2017) Tricyclic antidepressants for preventing migraine in adults. Medicine (Baltimore) 96:e6989

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gesellschaft zur Forschung und Beratung im Bereich Arzneimittelversorgung mbH, PharmaFacts, Freiburg, Deutschland

    Dr. rer. nat. Judith Günther

  2. Institut für Pharmakologie der Universität zu Köln, Köln, Deutschland

    Priv. Doz. Dr. med. Jan Matthes

Authors
  1. Dr. rer. nat. Judith Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priv. Doz. Dr. med. Jan Matthes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judith Günther .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Ulrich Schwabe

  2. Köln, Nordrhein-Westfalen, Germany

    Dieter Paffrath

  3. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ), Berlin, Berlin, Germany

    Wolf-Dieter Ludwig

  4. Wissenschaftliches Institut der AOK, Berlin, Berlin, Germany

    Jürgen Klauber

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Günther, J., Matthes, J. (2019). Migränemittel. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59046-1_35

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59045-4

  • Online ISBN: 978-3-662-59046-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation